Metbufen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H16O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8AE88M5N5V, chemically known as propionic acid, 3-(4-biphenylylcarbonyl)-2-methyl- but generally known as metbufen, which bears US NIH Compound Identifier 68823. European Medicines Agency schedules Metbufen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08821MIG. The term METBUFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). METBUFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metbufen under HS 29183000 and SITC 51395. As of Q4 2014, METBUFEN remains the US FDA Preferred Term for this commodity. Metbufen bears US NLM identifiers UMLS ID C0066064 and NCI Concept Code C90903. SMILES: O=C(CC(C)C(=O)O)C1CCC(CC1)C1CCCCC1.